These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 14584518
1. Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures. Albin M, Björk J, Welinder H, Tinnerberg H, Mauritzson N, Billström R, Strömberg U, Mikoczy Z, Johansson B, Ahlgren T, Nilsson PG, Mitelman F, Hagmar L. Scand J Work Environ Health; 2003 Oct; 29(5):378-87. PubMed ID: 14584518 [Abstract] [Full Text] [Related]
2. Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia? Björk J, Albin M, Welinder H, Tinnerberg H, Mauritzson N, Kauppinen T, Strömberg U, Johansson B, Billström R, Mikoczy Z, Ahlgren T, Nilsson PG, Mitelman F, Hagmar L. Occup Environ Med; 2001 Nov; 58(11):722-7. PubMed ID: 11600728 [Abstract] [Full Text] [Related]
3. Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure. West RR, Stafford DA, White AD, Bowen DT, Padua RA. Blood; 2000 Mar 15; 95(6):2093-7. PubMed ID: 10706879 [Abstract] [Full Text] [Related]
4. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study. Ciccone G, Mirabelli D, Levis A, Gavarotti P, Rege-Cambrin G, Davico L, Vineis P. Cancer Genet Cytogenet; 1993 Jul 15; 68(2):135-9. PubMed ID: 8353805 [Abstract] [Full Text] [Related]
5. Smoking and myelodysplastic syndromes. Björk J, Albin M, Mauritzson N, Strömberg U, Johansson B, Hagmar L. Epidemiology; 2000 May 15; 11(3):285-91. PubMed ID: 10784245 [Abstract] [Full Text] [Related]
10. Cytogenetic findings in primary and secondary MDS. Heim S. Leuk Res; 1992 May 15; 16(1):43-6. PubMed ID: 1732669 [Abstract] [Full Text] [Related]
11. Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study. Nisse C, Lorthois C, Dorp V, Eloy E, Haguenoer JM, Fenaux P. Leukemia; 1995 Apr 15; 9(4):693-9. PubMed ID: 7723405 [Abstract] [Full Text] [Related]
12. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, Minotto C, Agostini P, De Angeli C, Del Senno L, Spanedda R, Castoldi G. Br J Haematol; 1998 Oct 15; 103(1):189-97. PubMed ID: 9792307 [Abstract] [Full Text] [Related]
13. Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents. Albin M, Björk J, Welinder H, Tinnerberg H, Mauritzson N, Johansson B, Billström R, Strömberg U, Mikoczy Z, Ahlgren T, Nilsson PG, Mitelman F, Hagmar L. Scand J Work Environ Health; 2000 Dec 15; 26(6):482-91. PubMed ID: 11201395 [Abstract] [Full Text] [Related]
14. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS). Yarosh R, Roesler MA, Murray T, Cioc A, Hirsch B, Nguyen P, Warlick E, Poynter JN. Cancer Causes Control; 2021 Mar 15; 32(3):241-250. PubMed ID: 33392905 [Abstract] [Full Text] [Related]
15. Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification. Mahmood R, Altaf C, Ahmed P, Khan SA, Malik HS. Turk J Haematol; 2018 May 25; 35(2):109-115. PubMed ID: 28588002 [Abstract] [Full Text] [Related]